The use of adalimumab in the management of refractory Crohn's disease.
Ho GT, Smith L, Aitken S, Lee HM, Ting T, Fennell J, Lees CW, Palmer KR, Penman ID, Shand AG, Arnott ID, Satsangi J.
Ho GT, et al. Among authors: palmer kr.
Aliment Pharmacol Ther. 2008 Feb 15;27(4):308-15. doi: 10.1111/j.1365-2036.2007.03583.x. Epub 2007 Dec 7.
Aliment Pharmacol Ther. 2008.
PMID: 18081730
Clinical Trial.